Medication Overuse and Medication Overuse Headache: Risk Factors, Comorbidities, Associated Burdens and Nonpharmacologic and Pharmacologic Treatment Approaches

Ping Kun Chen, Shuu Jiun Wang*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Purpose of Review: With a worldwide high disease burden, medication overuse headache (MOH) is an endemic and disabling neurological disorder. Because of the limitations of previous study designs, there are still debates and questions regarding the disease’s nature and treatment strategy. This review will discuss the following concepts; (1) recent progress in association between medication overuse (MO) and MOH; (2) the burden, risk factors and comorbidities of MOH; (3) evidence of treatment in patients with MOH. Recent Findings: The causal relationship between MO and MOH has not been identified. Currently, the treatment policy is still mainly based on small clinical observations, some with highly specified patients. In addition to withdrawal and preventive treatment, some studies have provided evidence for nonpharmacological treatments. Summary: Well-designed studies for specific treatment strategies with enough statistical power are warranted to make more relevant, better clinical decisions.

Original languageEnglish
Article number60
JournalCurrent Pain and Headache Reports
Volume23
Issue number8
DOIs
StatePublished - 1 Aug 2019

Keywords

  • Chronic daily headache
  • Chronic migraine
  • Comorbidities
  • Medication overuse headache
  • Risk factors
  • Treatment

Fingerprint

Dive into the research topics of 'Medication Overuse and Medication Overuse Headache: Risk Factors, Comorbidities, Associated Burdens and Nonpharmacologic and Pharmacologic Treatment Approaches'. Together they form a unique fingerprint.

Cite this